Way it is implemented as well which is important. And 1 way it is implemented as well which is important. And the efforts they the sacrifices and the efforts they are making on behalf of us all. And could i ask the chief scientific adviser, matt hancock, the Health Secretary, mentioned last week that a surveillance study was being carried out with an Antibody Test that we developed by Public Health hello. This is bbc news. Im reeta england. Could you tell us what the early results of that show in terms of how many people in britain have chakrabarti. Hello. This is bbc news. Im reeta chakra barti. The hello. This is bbc news. Im reeta had the virus and how many would you chakrabarti. The Headlines Police expect to had have it in the 12 18 have been carrying out spot checks months or so until the vaccine is as people are urged to stick to social distancing rules. We have a developed . Thank you. They are good ha rd core of social distancing rules. We have a hard core of a few people, it
Authorities in new york and la advise people to wear face masks when theyre outdoors but President Trumps chief scientific adviser says masks shouldnt lead americans into a false sense of security. Spain registers more than 900 deaths for the second day in a row. But there are signs the european death rate is approaching its peak. Hello and welcome to audiences in the uk and around the world, for all the latest developments in the coronavirus pandemic. More than a Million People globally have been infected with coronavirus, a doubling of the total in the past week. In all, more than 50,000 people have died since the outbreak began in china in december. Here in britain the Health Secretary, matt hancock, has this morning acknowledged that the governments aim to deliver 100,000 daily coronvirus tests in england by the end of the month is going to be a huge undertaking. His comments come as the first nhs Nightingale Hospital prepares to open at the excel centre in londons docklands later.
Susan Clement-Davies and Professor Sir Robert Lechler join the Board on 1 January 2022 MiNA Therapeutics Limited ("MiNA" or the "Company"), the pioneer in small activating RNA (RNAa) therapeutics